PHASE-I AND PHASE-II TRIAL OF 5-DAY INFUSED 5-FLUOROURACIL AND RADIATION IN ADVANCED CANCER OF THE HEAD AND NECK

被引：74

作者：

BYFIELD, JE

SHARP, TR

FRANKEL, SS

TANG, SG

CALLIPARI, FB

机构：

[1] VET ADM MED CTR, DEPT RADIOL, LA JOLLA, CA 92037 USA

[2] UNIV CALIF SAN DIEGO, SCH MED, DIV RADIAT ONCOL, LA JOLLA, CA 92093 USA

[3] SAN DIEGO TUMOR INST, SAN DIEGO, CA USA

来源：

关键词：

D O I：

10.1200/JCO.1984.2.5.406

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：406 / 413

页数：8

共 27 条

[1] BAGSHAW MA, 1961, AMER J ROENTGENOL RA, V85, P822
[2] BARONE RM, 1982, CANCER, V50, P850, DOI 10.1002/1097-0142(19820901)50:5<850::AID-CNCR2820500508>3.0.CO
[3] 2-2
[4] BYFIELD JE, 1983, CANCER TREAT REP, V67, P933
[5] PHARMACOLOGIC REQUIREMENTS FOR OBTAINING SENSITIZATION OF HUMAN-TUMOR CELLS-INVITRO TO COMBINED 5-FLUOROURACIL OR FTORAFUR AND X-RAYS
BYFIELD, JE
CALABROJONES, P
KLISAK, I
KULHANIAN, F
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1982, 8 (11): : 1923 - 1933
[6] BYFIELD JE, 1983, CANCER TREAT REP, V67, P709
[7] BYFIELD JE, 1980, CANCER-AM CANCER SOC, V45, P703, DOI 10.1002/1097-0142(19800215)45:4<703::AID-CNCR2820450415>3.0.CO
[8] 2-Q
[9] BYFIELD JE, AM J CLIN ONCOL
[10] BYFIELD JE, CANCER RES